Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
09/2012
09/07/2012WO2012119074A1 Apparatus and method for organizing three-dimensional cell structures using stiffness gradients and sacrificial gels
09/07/2012WO2012091571A3 Combination of components for the prevention and treatment of frailty
09/06/2012US20120226347 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
09/06/2012US20120225920 Compositions and Methods for Non-Surgical Treatment of Ptosis
09/06/2012US20120225918 Compositions and Methods for Non-Surgical Treatment of Ptosis
09/06/2012US20120225883 Compounds for inflammation and immune-related uses
09/06/2012US20120225879 Substituted 5-imino-1,2,4-thiadiazoles that can be used to treat neurodegenerative diseases
09/06/2012US20120225857 Mst1 kinase inhibitors and methods of their use
09/06/2012US20120225840 Hydroxytyrosol combinations for enhancing mitochondrial function and energy production
09/06/2012US20120225139 Method and Composition for Improved Anabolism
09/06/2012US20120225118 Compositions for delivery of insoluble agents
09/06/2012US20120225049 Fast acting snare-cleaving enzymes
09/06/2012US20120225032 Dimeric Alpha Interferon PEGylated Site-Specifically Shows Enhanced and Prolonged Efficacy in Vivo
09/06/2012US20120225012 Composition for hard tissue repair
09/05/2012CN1636572B Compositions and methods for treatment of mitochondrial diseases
09/05/2012CN1520424B Immunoglobulins 2
09/05/2012CN102018863B Medicine paste with functions of diminishing inflammation, relieving pain, activating blood circulation and dissipating blood stasis and manufacturing method thereof
09/04/2012US8258288 RNA interference mediated inhibition of respiratory syncytial virus (RSV) expression using short interfering nucleic acid (siNA)
09/04/2012CA2507429C Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
08/2012
08/30/2012WO2012116176A2 Asymmetric ureas and medical uses thereof
08/30/2012WO2012053012A3 Topical pharmaceutical compositions comprising tfflocolchicoside
08/30/2012US20120220922 Photolabile compounds
08/30/2012US20120220631 USE OF 5H-THIOENO(3,4-c)PYRROLE-4,6-DIONE DERIVATIVES AS TUMOR NECROSIS FACTOR INHIBITOR
08/30/2012US20120220629 Asymmetric ureas and medical uses thereof
08/30/2012US20120220599 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists
08/30/2012US20120220586 Heterocyclic compounds and their uses
08/30/2012US20120220585 Heterocyclic compounds and their uses
08/30/2012US20120219592 Use of B-Aminoalcohols in the Treatment of Inflammatory Disorders and Pain
08/30/2012US20120219567 Methods Relating to Peripheral Administration of Nogo Receptor Polypeptides
08/30/2012US20120219546 Methods for treating conditions mediated by the inflammatory cytokine cascade using gapdh inhibitors
08/30/2012US20120219510 Natural extract from whole banana fruit (musa spp)
08/29/2012EP2490702A1 Treatment using reprogrammed mature adult cells
08/29/2012CN102648946A Warm compression thermal therapy liquid and preparation method thereof
08/29/2012CN102648906A Application of sunitinib in preparation of acetylcholinesterase inhibitor
08/29/2012CN101516390B Agent for preventing development of reflex sympathetic dystrophy after stroke
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252815 Nociceptin analogs
08/28/2012CA2476939C Pharmaceutical combinations of cox-2 inhibitors and opiates
08/28/2012CA2454073C Mutations in ion channels
08/23/2012WO2012112919A1 Stromal derived factor inhibition and cxcr4 blockade
08/23/2012WO2012112492A1 4-hydroxybutyric acid deuterated analogs
08/23/2012WO2012092035A9 Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
08/23/2012WO2012064090A9 Chemical preparation method of skeletal muscle-derived multipotent cells and use thereof
08/23/2012US20120214873 Cysteine for physiological injection
08/23/2012US20120214866 Treatment with cytokines
08/23/2012US20120214860 Method of regulating the expression level of survival of motor neuron 1 (smn1) and detecting enzyme activity of ubiquitin carboxyl-terminal hydrolase l1 (uchl1)
08/23/2012US20120214854 Carboxy oxazole or thiazole compounds as dgat- 1 inhibitors useful for the treatment of obesity
08/23/2012US20120214847 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
08/23/2012US20120214841 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/23/2012US20120214817 Urotensin ii receptor antagonists
08/23/2012US20120214737 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by nrg-2
08/23/2012US20120213823 Compositions comprising polyunsaturated fatty acid monoglycerides, derivatives thereof and uses thereof
08/23/2012US20120213760 Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(mtm1) polypeptides
08/23/2012US20120213755 Semi-synthetic platelet gel and method for the preparation thereof
08/23/2012US20120213751 Novel stem cells, nucleotide sequences and proteins therefrom
08/23/2012US20120213744 Compositions and methods for modulating stem cells and uses thereof
08/23/2012US20120213737 Compositions and methods for therapeutic membrane repair
08/23/2012US20120213731 Methods and compositions for treating autoimmune diseases
08/22/2012EP2488645A1 Exon skipping therapy for dysferlinopathies
08/22/2012EP2488643A1 Chimeric fibroblast growth factors with altered receptor specificity
08/22/2012EP2488165A1 Nanoparticle of the core-shell type suitable for delivering therapeutic oligonucleotides to target tissues and the use thereof for the preparation of a medicament for treating duchenne muscular dystrophy
08/22/2012EP1507780B1 Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
08/22/2012CN102647990A Methods of attenuating the loss of functional status
08/22/2012CN102647989A Treatment using reprogrammed mature adult cells
08/22/2012CN102643344A Binding constructs and methods for use thereof
08/22/2012CN102641490A Medicinal extract for treating facial nerve paralysis
08/22/2012CN102641338A Massage medicament for treating soft tissue injury
08/21/2012CA2555457C A novel therapeutic agent for amyotrophic lateral sclerosis (als) or diseases caused by als
08/21/2012CA2543793C Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain
08/21/2012CA2469076C Pharmaceutical compositions comprising dihydropyridinone compounds and an immunoregulatory or an antiinflammatory agent and their uses
08/21/2012CA2449284C Alpha-fetoprotein peptides and uses thereof
08/16/2012WO2012109570A1 Viral vectors with modified transduction profiles and methods of making and using the same
08/16/2012WO2012109296A1 Antisense oligonucleotides
08/16/2012WO2012108478A1 Monocyclic compound
08/16/2012US20120209050 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
08/16/2012US20120208865 Exon skipping therapy for dysferlinopathies
08/16/2012US20120208785 Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses
08/16/2012US20120207720 Laminins, derivatives, and compositions including same and methods for their therapeutic use
08/16/2012US20120207716 Cardiac Muscle Regeneration Using Mesenchymal Stem Cells
08/16/2012US20120207670 Method for Treating Psoriasis by Administering An Anti-IL-12 Antibody
08/16/2012CA2826836A1 Antisense oligonucleotides
08/16/2012CA2826273A1 Viral vectors with modified transduction profiles and methods of making and using the same
08/15/2012EP2485740A1 Methods for preventing or treating sarcopenia and muscle atrophy in animals
08/15/2012EP1294391B1 Combination of agents for inhibiting transplant rejection
08/15/2012CN102631644A External-use traditional Chinese medicine for treating myositis ossificans
08/15/2012CN102631369A Application of bone marrow mesenchymal stem cells (MSCs) to preparation of drugs for treating autoimmune diseases
08/15/2012CN102631368A Application of bone marrow mesenchymal stem cells (MSCs) to preparation of drugs for treating autoimmune diseases
08/15/2012CN101678020B Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of Janus kinases
08/14/2012CA2497845C Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols
08/09/2012US20120202879 Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy
08/09/2012US20120202876 Methods of treating diseases with proanthocyanidin oligomers such as crofelemer
08/09/2012US20120202829 6-Cycloalkyl-pyrazolopyrimidinones for the Treatment of CNS Disorders
08/09/2012US20120202810 Substituted 4-aminocyclohexane derivatives
08/09/2012US20120202769 Fgf receptor-activating n-sulfate oligosaccharides, preparation thereof, and therapeutic use thereof
08/09/2012US20120202752 Antisense Oligonucleotides
08/09/2012US20120202746 Daptomycin for multiple sclerosis
08/09/2012US20120202733 Inhibition of trem receptor signaling with peptide variants
08/09/2012US20120201872 Liposomes comprising a calcium phosphate-containing precipitate
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201818 Treatment of multiple sclerosis
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 233